Ensigna Biosystems uses a network of experienced consultant pathologists to perform discovery and toxicologic pathology.
Dr. Jitakshi De has been a pathology consultant for Ensigna Biosystems since 2017. She is also the founder of KromePath, a consulting company, as well as a Fellow of the American Society of Clinical Pathology, the College of American Pathologists, and a member of pathology, hematology, and cytometry professional societies.
She received her M.D. from Duke University, completed pathology residency at the UTHSC of Houston and her fellowship in Hematopathology at The University of Michigan. Her research interests include target-specific peptide discovery from a combinatorial peptide library, prognostic factors and phenotypic-genotypic correlations in acute and chronic leukemia, and immunocytochemical analysis of purified hematopoietic stem cells. She also has applied novel algorithms for statistical pattern recognition to identify and characterize leukemic stem/progenitor cells through high dimensional cytometry analysis of cell signaling pathways.
She has more than 8 years of experience in pathology practice in hospital and commercial laboratory settings. She brings a deep mechanistic understanding of assay development and validation of novel biomarkers in oncology and in autoimmune, infectious, and metabolic disorders.
Preferred Tissue Provider
BIO|OPTIONS provides human tissues and biological materials to researchers and scientists for molecular and genomicc research. We have been working with them for the past several years and have been extremely satisfied with the quality and the pricing of their tissues.
BIO|OPTIONS is physician owned and operated. They understand the needs of research scientists and how to procure the best biospecimens to ensure experimental success. They possess extensive experience in sample collection ensuring that proper protocols are followed, correct consents obtained and samples comprehensively annotated.